Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma

Histology and Histopathology

Volumn 28, Issue 12, 2013, Pages 1555-1566

  Montironi, Rodolfo ^a   Mazzucchelli, R ^a   Scarpelli, M ^a   Lopez Beltran, A ^b   Cheng, Liang ^c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clear cell (tubulo) papillary renal cell carcinoma clear cell papillary renal cell carcinoma; Clear cell renal cell carcinoma; Multilocular cystic CCRCC; Xp11 translocation renal cell carcinoma

Indexed keywords

CLASSIFICATION; GENE TRANSLOCATION; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; PATHOLOGY; PROGNOSIS; REVIEW; X CHROMOSOME;

CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, X; HUMANS; KIDNEY NEOPLASMS; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 84888126942     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Adam J., Couturier J., Molinié V., Vieillefond A. and Sibony M. (2011). Clear-cell papillary renal cell carcinoma: 24 cases of a distinct lowgrade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology 58, 1064-1071.
2. Algaba F., Akaza H., Lopez-Beltran A., Martignoni G., Moch H., Montironi R. and Reuter V. (2011). Current pathology keys of renal cell carcinoma. Eur. Urol. 60, 634-643.
3. Argani P., Antonescu C.R., Illei P.B., Lui M.Y., Timmons C.F., Newbury R., Reuter V.E., Garvin A.J., Perez-Atayde A.R., Fletcher J.A., Beckwith J.B., Bridge J.A. and Ladanyi M. (2001). Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am. J. Pathol. 159, 179-192.
4. Argani P., Antonescu C.R., Couturier J., Fournet J.C., Sciot R., Debiec-Rychter M., Hutchinson B., Reuter V.E., Boccon-Gibod L., Timmons C., Hafez N. and Ladanyi M. (2002). PRCC-TFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am. J. Surg. Pathol. 26, 1553-1566.
5. Argani P., Lui M.Y., Couturier J., Bouvier R., Fournet J.C. and Ladanyi M. (2003a). A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 22, 5374-5378.
6. Argani P., Lal P., Hutchinson B., Lui M.Y., Reuter V.E. and Ladanyi M. (2003b). Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 27, 750-761.
7. Argani P., Laé M., Ballard E.T., Amin M., Manivel C., Hutchinson B., Reuter V.E. and Ladanyi M. (2006). Translocation carcinomas of the kidney after chemotherapy in childhood. J. Clin. Oncol. 24, 1529-1534.
8. Argani P., Olgac S., Tickoo S.K., Goldfischer M., Moch H., Chan D.Y., Eble J.N., Bonsib S.M., Jimeno M., Lloreta J., Billis A., Hicks J., De Marzo A.M., Reuter V.E. and Ladanyi M. (2007) Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 31, 1149-1160.
9. Argani P., Hicks J., De Marzo A.M., Albadine R., Illei P.B., Ladanyi M., Reuter V.E. and Netto G.J. (2010). Xp11 Translocation Renal Cell Carcinoma (RCC): Extended Immunohistochemical (IHC) Profile Emphasizing Novel RCC Markers. Am. J. Surg. Pathol. 34, 1295-1303.
10. Aydin H., Chen L., Cheng L., Vaziri S., He H., Ganapathi R., Delahunt B., Magi-Galluzzi C. and Zhou M. (2010). Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am. J. Surg. Pathol. 34, 1608-1621.
11. Behdad A., Monzon F.A. and Hes O. (2011). Relationship between sporadic clear cell-papillary renal cell carcinoma (CP-RCC) and renal angiomyoadenomatous tumor (RAT) of the kidney: analysis by virtual-karyotyping, fluorescent in situ analysis and immunohistochemistry (IHC). Mod. Pathol. 24, 179A.
12. Bhatnagar R. and Alexiev B.A. (2012). Renal-Cell Carcinomas in End-Stage Kidneys: A clinicopathological study with emphasis on clearcell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma. Int. J. Surg. Pathol. 20, 19-28.
13. Brunelli M., Menestrina F. and Segala D. (2009). Renal cell carcinoma associated with prominent leiomyomatous proliferation appears not to be a variant of clear cell renal cell carcinoma. Mod. Pathol. 22, 160A-161A.
14. Brunelli M., Fiorentino M., Gobbo S., Sperandio N., Cheng L., Cossu-Rocca P., Segala D., Eble J.N., Delahunt B., Novara G., Ficarra V., and Martignoni G. (2011). Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors. Histol. Histopathol. 26, 1207-1213.
15. Chen Y.B. and Tickoo S.K. (2012). Spectrum of preneoplastic and neoplastic cystic lesions of the kidney. Arch. Pathol. Lab. Med. 136, 400-409.
16. Cheng L., Williamson S.R., Zhang S., MacLennan G.T., Montironi R., and Lopez-Beltran A. (2010). Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy. Expert Rev. Anticancer Ther. 10, 843-864.
17. Clark J., Lu Y.J., Sidhar S.K., Parker C., Gill S., Smedley D., Hamoudi R., Linehan W.M., Shipley J. and Cooper C.S. (1997). Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15, 2233-2239.
18. Enoki Y., Katoh G., Okabe H. and Yanagisawa A. (2010). Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis. Histopathology 56, 384-394.
19. Ficarra V., Brunelli M., Cheng L., Kirkali Z., Lopez-Beltran A., Martignoni G., Montironi R., Novara G. and Van Poppel H. (2010). Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors. Eur. Urol. 58, 655-668.
20. Geller J.I., Argani P., Adeniran A., Hampton E., De Marzo A., Hicks J. and Collins M.H. (2008). Translocation renal cell carcinoma: Lack of negative impact due to lymph node spread. Cancer 112, 1607-1616.
21. Gobbo S., Eble J.N., MacLennan G.T., Grignon D.J., Shah R.B., Zhang S., Martignoni G., Brunelli M., and Cheng L. (2008a). Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am. J. Surg. Pathol. 32, 1780-1786.
22. Gobbo S., Eble J.N., Grignon D.J., Martignoni G., MacLennan G.T., Shah R.B., Zhang S., Brunelli M. and Cheng L. (2008b). Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am. J. Surg. Pathol. 32,1239-1245.
23. Goyal R., Gersbach E., Yang X.J. and Rohan S.M. (2013). Differential diagnosis of renal tumors with clear cytoplasm clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine. Arch. Pathol. Lab. Med. 137, 467-480.
24. Green W.M., Yonescu R., Morsberger L., Morris K., Netto G.J., Epstein J.I., Illei P.B., Allaf M., Ladanyi M., Griffin C.A. and Argani P. (2013) Utilization of a TFE3 break apart FISH assay in a renal tumor consultation service. Am. J. Surg. Pathol. 37, 1150-1163.
25. Halat S., Eble J.N., Grignon D.J., Lopez-Beltran A., Montironi R., Tan P.H., Wang M., Zhang S., MacLennan G.T. and Cheng L. (2010). Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod. Pathol. 23, 931-936.
26. Iczkowski K.A., Shanks J.H., Burdge A.H., and Cheng L. (2013). Renal cell carcinoma with clear cells, smooth muscle stroma, and negative for 3p deletion: a variant of renal angiomyoadenomatous tumour? A case report. Histopathology 62, 522-524.
27. Komai Y., Fujiwara M., Fujii Y., Mukai H., Yonese J., Kawakami S., Yamamoto S., Migita T., Ishikawa Y., Kurata M., Nakamura T. and Fukui I. (2009). Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin. Cancer Res. 15, 1170-1176.
28. Kuhn E., De Anda J., Manoni S., Netto G. and Rosai J. (2006). Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: Report of 5 cases and review of the literature. Am. J. Surg. Pathol. 30, 1372-1381.
29. Kuroda N., Tamura M., Tanaka Y., Hes O., Michal M., Inoue K., Ohara M., Mizuno K. and Lee G.H. (2009). Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels. Pathol. Int. 59, 486-491.
30. Kuroda N., Shiotsu T., Hes O., Michal M., Shuin T. and Lee G.H. (2010). Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med. Mol. Morphol. 43, 231-234.
31. Kuroda N., Hosokawa T., Michal M., Hes O., Sima R., Ohe C. and Lee G.H. (2011a). Clear cell renal cell carcinoma with focal renal angiomyoadenomatous tumor-like area. Ann. Diagn. Pathol. 15, 202-206.
32. Kuroda N., Yamashita M., Kakehi Y., Hes O., Michal M. and Lee G.H. (2011b). Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study. Med. Mol. Morphol. 44, 228-232.
33. Kuroda N., Ohe C., Mikami S., Inoue K., Nagashima Y., Cohen R.J., Pan C.C., Michal M. and Hes O. (2012). Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol. Histopathol. 27, 969-974.
34. Ladanyi M., Lui M.Y., Antonescu C.R., Krause-Boehm A., Meindl A., Argani. P, Healey J.H., Ueda T., Yoshikawa H., Meloni-Ehrig A., Sorensen P.H., Mertens F., Mandahl N., van den Berghe H., Sciot R., Dal Cin P. and Bridge J. (2001). The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20, 48-57.
35. Lopez-Beltran A., Scarpelli M., Montironi R. and Kirkali Z. (2006). 2004 WHO classification of the renal tumors of the adults. Eur. Urol. 49, 798-805.
36. Macher-Goeppinger S., Roth W., Wagener N., Hohenfellner M., Penzel R., Haferkamp A., Schirmacher P. and Aulmann S. (2012). Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod. Pathol. 25, 308-315.
37. MacLennan G.T. and Cheng L. (2011). Tubulocystic carcinoma of the kidney. J. Urol. 185, 2348-2349.
38. MacLennan G.T. and Cheng L. (2014). Neoplasms of the kidney. In: Urologic surgical pathology. 3rd ed. Bostwick D.G. and Cheng L. (eds). Elsevier. New York, NY.
39. Mai K.T., Kohler D.M., Belanger E.C., Robertson S.J. and Wang D. (2008). Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity. Pathology 40, 481-486.
40. Martignoni G., Pea M., Gobbo S., Brunelli M., Bonetti F., Segala D., Pan C.C., Netto G., Doglioni C., Hes O., Argani P. and Chilosi M. (2009). Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod. Pathol. 22, 1016-1022.
41. Martignoni G., Gobbo S., Camparo P., Brunelli M., Munari E., Segala D., Pea M., Bonetti F., Illei P.B., Netto G.J., Ladanyi M., Chilosi M. and Argani P. (2011). Differential expression of cathepsin-K in neoplasms harbouring TFE3 gene fusions. Mod. Pathol. 24,1313-1319.
42. Mazzucchelli R., Scarpelli M., Montironi R., Cheng L., and Lopez-Beltran A. (2012). Multilocular cystic renal cell neoplasms of low malignant potential. Anal. Quant. Cytol. Histol. 34, 235-238.
43. Meyer P.N., Clark J.I., Flanigan R.C. and Picken M.M. (2007). Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am. J. Clin. Pathol. 128, 70-79.
44. Michal M., Hes O. and Havlicek F. (2000). Benign renal angiomyoadenomatous tumor: A previously unreported renal tumor. Ann. Diagn. Pathol. 4, 311-315.
45. Michal M., Hes O., Nemcova J., Sima R., Kuroda N., Bulimbasic S., Franco M., Sakaida N., Danis D., Kazakov D.V., Ohe C. and Hora M. (2009a). Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 454, 89-99.
46. Michal M., Hes O., Kuroda N., Kazakov D.V. and Hora M. (2009b). Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma. Virchows Arch. 454, 719.
47. Moch H. (2010). Cystic renal tumors: new entities and novel concepts. Adv. Anat. Pathol. 17, 209-214.
48. Montironi R., Lopez-Beltran A., Cheng L., and Scarpelli M. (2013). Words of wisdom: re: multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur. Urol. 63, 400-401.
49. Mosquera J.M., Dal Cin P., Mertz K.D., Perner S., Davis I.J., Fisher D.E., Rubin M.A. and Hirsch M.S. (2011). Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma. Diagn. Mol. Pathol. 20,129-137.
50. Nickerson M.L., Jaeger E., Shi Y., Durocher J.A., Mahurkar S., Zaridze D., Matveev V., Janout V., Kollarova H., Bencko V., Navratilova M., Szeszenia-Dabrowska N., Mates D., Mukeria A., Holcatova I., Schmidt L.S., Toro J.R., Karami S., Hung R., Gerard G.F., Linehan W.M., Merino M., Zbar B., Boffetta P., Brennan P., Rothman N., Chow W.H., Waldman F.M. and Moore L.E. (2008). Improved identification of von hippel-lindau gene alterations in clear cell renal tumors. Clin. Cancer Res. 14, 4726-4734.
51. Rao Q., Liu B., Cheng L., Zhu Y., Shi Q.L., Wu B., Jiang S.J., Wang Y., Wang X., Yu B., Zhang R.S., Ma H.H., Lu Z.F., Tu P., Wang J.D., and Zhou X.J. (2012). Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization. Am. J. Surg. Pathol. 36, 1327-1338.
52. Rao Q., Cheng L., Xia Q.Y., Liu B., Li L., Shi Q.L., Shi S.S., Yu B., Zhang R.S., Ma H.H., Lu Z.F., Tu P., and Zhou X.J. (2013a). Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas. Histopathology 62, 642-650.
53. Rao Q., Williamson S.R., Zhang S., Eble J.N., Grignon D.J., Wang M., Zhou X.J., Huang W., Tan P.H., MacLennan G.T., and Cheng L. (2013b). TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am. J. Surg. Pathol. 37, 804-815.
54. Reuter V.E. and Tickoo S.K. (2009) Adult renal tumors. In: Sternberg's diagnostic surgical pathology. 5th ed. Mills S.E. (ed). Lippincott Williams & Wilkins. Philadelphia. pp 1757-1798.
55. Rohan S.M., Xiao Y., Liang Y., Dudas M.E., Al-Ahmadie H.A., Fine S.W., Gopalan A., Reuter V.E., Rosenblum M.K., Russo P. and Tickoo S.K. (2011). Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathwayrelated proteins. Mod. Pathol. 24, 1207-1220.
56. Shannon B.A., Cohen R.J., Segal A., Baker E.G. and Murch A.R. (2009). Clear cell renal cell carcinoma with smooth muscle stroma. Hum. Pathol. 40, 425-429.
57. Srigley J.R. and Delahunt B. (2009). Uncommon and recently described renal carcinomas. Mod. Pathol. 22, S2-S23.
58. Srigley J., Delahunt B., Eble J.N., Egevad L., Epstein J.I., Grignon D., Hes O., Moch H., Montironi R., K. Tickoo S., Zhou M., Argani P. and the ISUP Renal Tumor Panel (2013). The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J. Surg. Pathol. 37, 1469-1489.
59. Stamatiou K.N. and Sofras F. (2009). Multilocular cystic nephroma and multicystic clear cell carcinoma: two faces of the Roman god Janus? Int. J. Surg. Pathol. 17, 170-171.
60. Sule N., Yakupoglu U., Shen S.S., Krishnan B., Yang G., Lerner S., Sheikh-Hamad D. and Truong L.D. (2005). Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am. J. Surg. Pathol. 29, 443-451.
61. Suzigan S., Lopez-Beltran A., Montironi R., Drut R., Romero A., Hayashi T., Gentili A.L., Fonseca P.S., deTorres I., Billis A., Japp L.C., Bollito E., Algaba F. and Requena-Tapias M.J. (2006). Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am. J. Clin. Pathol. 125, 217-222.
62. Tickoo S.K. and Reuter V.E. (2011). Differential diagnosis of renal tumors with papillary architecture. Adv. Anat. Pathol. 18, 20-32.
63. Tickoo S.K., dePeralta-Venturina M.N., Harik L.R., Worcester H.D., Salama M.E., Young A.N., Moch H. and Amin M.B. (2006). Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am. J. Surg. Pathol. 30, 141-153.
64. van den Berg A. and Buys C.H. (1997). Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosomes Cancer 19, 59-76.
65. von Teichman A., Compérat E., Behnke S., Storz M., Moch H. and Schraml P. (2011). VHL mutations and dysregulation of pVHL-and PTEN-controlled pathways in multilocular cystic renal cell carcinoma. Mod. Pathol. 24, 571-578.
66. Williamson S.R., Halat S., Eble J.N., Grignon D.J., Lopez-Beltran A., Montironi R., Tan P.H., Wang M., Zhang S., MacLennan G.T., Baldridge L.A., and Cheng L. (2012). Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am. J. Surg. Pathol. 36, 1425-1433.
67. Williamson S.R., Eble J.N., Cheng L., and Grignon D.J. (2013a). Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod. Pathol. 26, 697-708.
68. Williamson S.R., MacLennan G.T., Lopez-Beltran A., Montironi R., Tan P.H., Martignoni G., Grignon D.J., Eble J.N., Idrees M.T., Scarpelli M., and Cheng L. (2013b). Cystic partially regressed clear cell renal cell carcinoma: A clinicopathologic study of 27 Cases emphasizing distinction from multilocular cystic renal cell carcinoma. Histopathology (In press).
69. Williamson S.R., Zhang S., Eble J.N., Grignon D.J., Martignoni G., Brunelli M., Wang M., Gobbo S., Baldridge L.A., and Cheng L. (2013c). Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Am. J. Surg. Pathol. 37, 1131-1139.
70. Wolfe A., Dobin S.M., Grossmann P., Michal M. and Donner L.R. (2011). Clonal trisomies 7,10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney. Virchows Arch. 459, 457-463.
71. You D., Shim M., Jeong I.G., Song C., Kim J.K., Ro J.Y., Hong J.H., Ahn H. and Kim C.S. (2011). Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computed tomography. BJU Int. 108, 1444-1449.
72. Zhong M., De Angelo P., Osborne L., Keane-Tarchichi M., Goldfischer M., Edelmann L., Yang Y., Linehan W.M., Merino M.J., Aisner S. and Hameed M. (2010). Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma. Am. J. Surg. Pathol. 34, 757-766.